Literature DB >> 27111695

Men's help-seeking in the first year after diagnosis of localised prostate cancer.

M K Hyde1,2, R U Newton3,4, D A Galvão3, R A Gardiner3,4,5, S Occhipinti1, A Lowe1,6, G A Wittert7, S K Chambers1,2,3,4,6.   

Abstract

This study describes sources of support utilised by men with localised prostate cancer in the first year after diagnosis and examines characteristics associated with help-seeking for men with unmet needs. A cross-sectional survey of 331 patients from a population-based sample who were in the first year after diagnosis (M = 9.6, SD = 1.9) was conducted to assess sources of support, unmet supportive care needs, domain-specific quality of life and psychological distress. Overall, 82% of men reported unmet supportive care needs. The top five needs were sexuality (58%); prostate cancer-specific (57%); psychological (47%); physical and daily living (41%); and health system and information (31%). Professional support was most often sought from doctors (51%). Across most domains, men who were older (Ps ≤ 0.03), less well educated (Ps ≤ 0.04) and more depressed (Ps ≤ 0.05) were less likely to seek help for unmet needs. Greater sexual help-seeking was related to better sexual function (P = 0.03), higher education (P ≤ 0.03) and less depression (P = 0.05). Unmet supportive care needs are highly prevalent after localised prostate cancer diagnosis with older age, lower education and higher depression apparent barriers to help-seeking. Interventions that link across medicine, nursing and community based peer support may be an accessible approach to meeting these needs. Clinical Trial Registry: Trial Registration: ACTRN12611000392965.
© 2016 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  help-seeking; prostate cancer; supportive care needs; survivorship

Mesh:

Year:  2016        PMID: 27111695      PMCID: PMC5347946          DOI: 10.1111/ecc.12497

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


Introduction

Globally, over 1 million new cases of prostate cancer were diagnosed in 2012 with 68% of these occurring in more developed countries (Ferlay et al. 2014). Prostate cancer incidence is highest in Australia/New Zealand, North America, Western and Northern Europe (age standardised rates per 100 000 range from 85.0 to 111.6), with incidence expected to increase globally to 1.7 million cases in 2030 (Center et al. 2012; Ferlay et al. 2014). Survival rates for prostate cancer have increased in most countries in the past two decades (Allemani et al. 2015) such that in the UK, North America and Australia/New Zealand approximately 90% of men now survive their prostate cancer at least 5 years and >80% survive for 10 years or more (Australian Institute of Health and Welfare 2013; Cancer Research UK 2014; American Cancer Society 2015). Although many more men are surviving prostate cancer, they are living with high and persistent symptom burdens often not addressed in follow‐up care (Smith et al. 2000; Bernat et al. 2015; Carlsson et al. 2015; Gavin et al. 2015). In a recent UK study, approximately one‐third of men up to 2 years post‐prostate cancer diagnosis reported concerns with sexual, urinary and bowel function (Watson et al. 2015) and there is evidence to suggest that these effects can persist for a decade or more (Bernat et al. 2015; Carlsson et al. 2015). As well, men who were younger or received multi‐modal treatment including androgen deprivation therapy (ADT) experienced worse effects (Smith et al. 2007; Carlsson et al. 2015). In addition to substantial symptom burden, prostate cancer survivors' supportive care needs are frequently not met (Steginga et al. 2001; Lintz et al. 2003; Smith et al. 2007; Chambers et al. 2015a,b; Watson et al. 2015). Up to one half of men report ongoing unmet sexuality, psychological, and health system and information needs after prostate cancer treatment (Steginga et al. 2001; Lintz et al. 2003; Smith et al. 2007; Bernat et al. 2015; Watson et al. 2015). Problematically, although prior studies suggest that men access health care services (Holden et al. 2005, 2006) at similar frequencies to women (Hourani et al. 2016), they often do not actively seek help (or receive treatment) for the full range of their concerns (Addis & Mahalik 2003; Shabsigh et al. 2004; Galdas et al. 2005; Steginga et al. 2008; Forsythe et al. 2013; Hyde et al. 2016; Yousaf et al. 2015) unless prompted to do so by a partner or a direct enquiry from a health professional (Holden et al. 2006). In particular, men with prostate cancer are less likely to discuss their social and emotional concerns with health care providers compared to women with breast cancer (Forsythe et al. 2013). Reasons for men's hesitancy to seek help may include under‐reporting of emotional, physical or sexual concerns (Kunkel et al. 2000; Holden et al. 2006; Bernat et al. 2015; Yousaf et al. 2015); somatisation of mental health symptoms (Kockler & Heun 2002; Fiske et al. 2009); self‐reliance and a desire to maintain a sense of normalcy (Gray et al. 2000; Yousaf et al. 2015); concerns about burdening others (Gray et al. 2000); discomfort or embarrassment (Yousaf et al. 2015); being less well educated or unaware (Dunn et al. 1999); and preference for self‐management (Klafke et al. 2014). However, although recent studies have identified the symptom burden and supportive care needs of prostate cancer survivors and the factors that contribute to these (Smith et al. 2000; McDowell et al. 2010, 2011; Bernat et al. 2015; Gavin et al. 2015; Watson et al. 2015), patterns of help‐seeking in this population to address unmet needs are less well described (Neese et al. 2003; Hyde et al. 2016). Rutten et al. (2005) propose that cancer patient's unmet needs and sources of support should be examined with specific reference to cancer survivorship stage (e.g., diagnosis, treatment, post‐treatment) in order to be responsive to context. For prostate cancer survivors, unmet supportive care needs are highest close to the time of treatment (Smith et al. 2007; Harrison et al. 2009). Accordingly, we describe men's patterns of help‐seeking in the first year after prostate cancer treatment, their unmet supportive care needs and from this examine factors related to help‐seeking in the context of unmet need.

Methods

Recruitment

Men who were diagnosed with localised prostate cancer in the state of Queensland, Australia were recruited between September 2011 and November 2012 via the Queensland Cancer Registry as part of a randomised controlled trial that is ongoing (Chambers et al. 2011; Galvão et al. 2015). Men were eligible for the trial if they had undergone/were undergoing prostate cancer treatment; could read and speak English; had no prior history of head injury, dementia or current psychiatric illness; had no concurrent cancer; and received clearance to participate from their physician. This study reports cross‐sectional baseline data from a sub‐group of men drawn from the larger population‐based cohort who were in the first year after diagnosis and had received treatment. The study was approved by the Griffith University Human Research Ethics Committee and human research ethics committees of hospitals across Queensland. All participants provided written informed consent.

Measures

Baseline assessment occurred via computer‐assisted telephone interview using previously validated and reliable self‐report measures (Chambers et al. 2011; Galvão et al. 2015).

Help‐seeking and sources accessed

Help‐seeking for prostate cancer‐related concerns since diagnosis was assessed using a self‐report yes/no measure. Type of help sought was measured with a prompted list on which men indicated all resources (e.g. Internet, brochures/books) and sources of support (e.g. doctor, nurse/other health professional, family/friends, support group) they had accessed for their concerns since diagnosis (McDowell et al., 2011; Hyde et al. 2016). An open‐ended response option was provided for men to indicate if they had used a resource or source of support that was not listed.

Unmet supportive care needs

The Supportive Care Needs Survey Short Form‐34 (SCNS‐SF34) measured men's need for help across psychological, health systems and information, patient care and support, physical and daily living, and sexuality domains (Boyes et al. 2009). A previously validated eight‐item prostate cancer‐specific module was also included to assess urinary, bowel, hormone and masculinity‐related sexuality (e.g. feeling like you've lost part of your manhood) needs (Steginga et al. 2001). Items were rated 1 (no need/not applicable), 2 (need was satisfied), 3 (low need), 4 (moderate need) or 5 (high need).

Disease‐specific quality of life

The domain summary scores from the Expanded UCLA Prostate Index Composite (EPIC) was applied to measure disease‐specific quality of life for urinary (α = 0.85), bowel (α = 0.87), sexual (α = 0.89) and hormonal (α = 0.69) function (Litwin et al. 1998; Wei et al. 2000). Scores for each domain were transformed to a 0–100 scale with higher scores indicating better functioning.

Distress

The Brief Symptom Inventory‐18 (BSI‐18) including subscales of anxiety (α = 0.73), depression (α = 0.86) and somatisation (α = 0.67) and a Global Severity Index (GSI) (α = 0.88) assessed psychological distress (Derogatis & Lopez 2000). Men reported the degree of distress experienced for each symptom in the week prior to assessment, scored 0 (not at all) to 4 (extremely), with higher scores indicating greater distress. Raw scores were converted to standardised t‐scores to identify men with clinically significant symptoms (Chambers et al. 2014). Consistent with previous studies of cancer patients, caseness was identified using a cut‐off t‐score ≥57 on the BSI‐18 GSI or on at least two of the BSI‐18 subscales (Zabora et al. 2001; Chambers et al. 2014).

Statistical analysis

Descriptive statistics were calculated for socio‐demographic and treatment characteristics, and to describe psychological distress, disease‐specific quality of life, unmet supportive care needs, help‐seeking and sources of help accessed. For men who expressed some level of need (scored ≥3) overall and in each SCNS‐SF34 domain (except patient care and support because too few men reported an unmet need on this domain), logistic regression was used to examine associations between help‐seeking and the following variables: age, education, months since diagnosis, hormone treatment; BSI‐18 somatic, depression, anxiety subscales; and EPIC urinary, bowel and sexual domain summary scores. The hormone summary score was not included in the analysis due to the small number of men who received ADT. Logistic regressions were also conducted to examine associations between the variables specified above and supportive care needs (except patient care and support).

Results

Recruitment and participant characteristics

Initially, 1899 patients were identified as potentially eligible for the trial and of these, 1770 doctors were contacted for permission to recruit their patients of whom 88.4% (n = 1564) gave consent to do so. Six hundred and seventy‐nine of 1501 patients contacted agreed to participate, of which 463 met eligibility criteria, gave consent and completed baseline assessment (Galvão et al. 2015). Within this group, 331 patients were in the first year after diagnosis and had received treatment for localised prostate cancer. Analyses in this study are based on data from this sub‐group of men. Mean age of men was 64.5 years (median = 65.0; SD = 7.6). Most were in a relationship (86%), educated at university/college (25%) or trade/technical (38%) level, and just over half had an income ≥AUD $60 000. Men were within the first 12 months of diagnosis (M = 9.6 months; median = 10.0; SD = 1.9). Men had received treatment approximately 6 months prior to the study (M = 6.4 months; median = 6.8; SD = 2.5), and most (68%) were treated with radical prostatectomy (Table 1).
Table 1

Patient socio‐demographic and treatment characteristics and EPIC domain summary scores (N = 331)

CharacteristicsMean (SD)/range or %
Age (years)64.5 (7.6)/44–89
Education (highest level completed)
University or college degree25.4
Trade/technical certificate/diploma38.4
Senior high school10.0
Junior high school19.9
Primary school6.0
Did not complete primary school0.3
Marital status
Married81.6
Defacto3.9
Divorced/separated4.5
Widowed1.2
Single8.8
Gross household income (AUD)
< $20 00011.2
$20 000 to $39 99923.0
$40 000 to $59 99914.2
$60 000 to $79 99912.7
$80 000+35.6
Don't know/unwilling to answer3.3
Months since diagnosis9.6 (1.9)/2.9–12.5
Months since treatment6.4 (2.5)/0.1–11.3
Treatment received
Radical prostatectomy68.9
EBRT with ADT13.0
EBRT without ADT2.7
Brachytherapy with ADT2.1
Brachytherapy without ADT5.4
EBRT & Brachytherapy with ADT1.5
ADT only2.7
Other3.6
EPIC domain summary scores
Urinary85.3 (15.6)
Bowel93.1 (11.0)
Hormonal80.6 (13.9)
Sexual36.0 (22.6)

ADT, androgen deprivation therapy; AUD, Australian dollars; EBRT, external beam radiation therapy; EPIC, expanded prostate cancer incidence composite.

Patient socio‐demographic and treatment characteristics and EPIC domain summary scores (N = 331) ADT, androgen deprivation therapy; AUD, Australian dollars; EBRT, external beam radiation therapy; EPIC, expanded prostate cancer incidence composite.

Disease‐specific quality of life

Table 1 reports EPIC domain summary scores and of these men reported few difficulties in the areas of urinary and bowel function and hormonal effects. By contrast, sexual function scores were lower. Specifically, 41% of men considered their sexual function to be a moderate/big problem in the month prior to baseline assessment; with 14.2% and 4.5% reporting urinary and bowel dysfunction, respectively, to be a moderate/big problem in the same time frame. Sixty‐four men received ADT and of these approximately 10% identified hot flushes, depression and body weight as a moderate/big problem. Lack of energy was a moderate/big problem for 22% of these men.

Psychological distress

The standardised mean BSI GSI was 45.5 (SD = 8.5, range 36–72), with mean subscale scores of 47.4 for somatisation (SD = 6.8, range 42–81), 46.3 for depression (SD = 7.2, range 42–77) and 45.2 for anxiety (SD = 7.5, range 39–72). Forty‐two men (12.7%) were identified as reaching high distress using the cut‐off specified (t‐score ≥57).

Unmet supportive care needs

Overall, 82% of men had some (low, moderate or high) level of need across any supportive care need domains. Of these, over half had concerns about sexuality (58%) and prostate cancer‐specific needs (57%) that were not addressed. Approximately, half reported psychological (47%) and physical and daily living (41%) needs, and less than one‐third had health system and information (31%) or patient care and support (17%) needs. Moderate–high need was expressed most frequently on sexuality (40%) and prostate cancer‐specific (34%) domains (Table 2). The top 10 items for which men reported moderate to high unmet needs are described in Table 2. Of these, sexuality needs caused the most concern or discomfort with approximately one‐third of men reporting they needed help with changes in sexual feelings and relationships and their sense of masculinity (feeling like a man). Physical needs, particularly not being able to do things as before, lack of energy/tiredness, and urinary incontinence were moderate–high concerns for ≥10% of men. Men also expressed moderate–high need for help with their own (10%) or close others' (12%) psychological well‐being, and their feelings of uncertainty about the future (9%). A moderate–high information need regarding being informed about things to do to get well was reported by 9% of men. Table 3 shows that men who experienced increased anxiety or somatic symptoms and were treated with ADT (vs. not treated) were more likely to express unmet supportive care needs across a range of need areas. Better outcomes on sexual, urinary and bowel domains and older age were associated with less unmet needs (Table 3). Education and months since diagnosis were not related to unmet needs.
Table 2

Supportive care needs domains and items (SCNS SF‐34) (N = 331)

Supportive care needsa , b Some need %No need or need satisfied %Low need %Moderate–high need %
Physical and daily living need40.559.518.122.4
Not being able to do the things you used to do24.875.210.314.5c
Lack of energy/tiredness24.875.214.810.0c
Feeling unwell a lot of the time8.791.33.05.7
Work around the home8.591.54.93.6
Pain6.693.43.03.6
Psychological need47.152.923.024.1
Concerns about the worries of those close to you23.077.011.211.8c
Fears about the cancer spreading21.578.512.78.8
Uncertainty about the future21.178.912.19.0c
Feeling down or depressed17.582.57.310.2c
Anxiety15.784.37.38.4
Feelings of sadness15.484.67.87.6
Worry that the results of treatment are beyond your control14.285.87.36.9
Learning to feel in control of your situation12.487.66.95.5
Feelings about death or dying9.190.95.83.3
Keeping a positive outlook8.291.83.94.3
Health system and information need30.869.210.320.5
Being informed about things you can do to help yourself get well14.585.55.59.0c
Having one member of staff with whom you can talk to about all aspects of your condition, treatment and follow‐up13.087.04.58.5
Having access to professional counselling (e.g. psychologist, social worker, counsellor, nurse specialist) if you, family or friends need it10.989.14.56.4
Being given information (written, diagrams, drawings) about aspects of managing your illness and side effects at home9.490.64.25.2
Being given explanations of those tests for which you would like explanations9.190.93.65.5
Being adequately informed about cancer which is under control or diminishing8.891.22.46.4
Being adequately informed about the benefits and side effects of treatments before you choose to have them8.591.52.46.1
Being informed about your test results as soon as feasible7.392.72.15.2
Being given written information about the important aspects of your care5.894.21.64.2
Being treated like a person not just another case5.794.31.83.9
Being treated in a hospital or clinic that is as physically pleasant as possible3.696.42.11.5
Patient care and support need16.783.36.710.0
Reassurance by medical staff that the way you feel is normal8.591.54.34.2
More choice about which cancer specialists you see6.493.61.84.6
More choice about which hospital you attend6.193.92.14.0
Hospital staff attending promptly to your physical needs5.494.62.72.7
Hospital staff acknowledging, and showing sensitivity to, your feelings and emotional needs2.497.60.61.8
Sexuality need58.042.017.840.2
Changes in sexual feelings47.752.318.729.0c
Changes in sexual relationships41.458.613.028.4c
To be given information about sexual relationships19.980.19.010.9c
Prostate cancer‐specific need57.442.623.034.4
Feeling like you've lost part of your manhood38.161.916.022.1c
Urinary incontinence26.074.012.713.3c
Problems with your bowel habits11.588.54.86.7
Hot flushesd 6.993.13.13.8
Difficulties in passing urine6.693.43.63.0
Feeling that what you say is not taken seriously by others9.490.64.54.9
Feeling as if you are going through a change of life like women dod 3.496.61.12.3
Feeling like you have lost the ability to be aggressive2.497.61.21.2

Level of need for help in the last month.

Need was scored 1–2 = no need/need satisfied, 3 = some need, 4–5 = moderate–high need.

Top 10 moderate–high supportive care need.

n = 262 (69 men receiving androgen deprivation therapy were excluded).

Table 3

Factors associated with unmet supportive care needs in men with prostate cancer (N = 331)

Supportive care needsAny needPhysical and daily living needPsychological needHealth system and info needSexuality needProstate cancer‐specific needa
FactorsOR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P
Age (years)0.96 (0.91–1.01)0.140.98 (0.94–1.02)0.24 0.92 (0.89–0.96) <0.001 0.95 (0.91–0.99) 0.02 0.92 (0.88–0.96) <0.001 0.97 (0.93–1.01)0.12
Education
University/collegeRef.Ref.Ref.Ref.Ref.Ref.
Trade/technical0.90 (0.42–1.96)0.791.22 (0.64–2.34)0.540.67 (0.36–1.27)0.221.67 (0.83–3.36)0.150.97 (0.51–1.86)0.920.62 (0.32–1.22)0.17
High school1.38 (0.59–3.22)0.461.30 (0.66–2.59)0.451.20 (0.62–2.31)0.591.52 (0.72–3.21)0.271.08 (0.55–2.13)0.831.41 (0.70–2.84)0.34
Primary school1.28 (0.40–4.17)0.691.06 (0.33–3.40)0.921.98 (0.62–6.29)0.251.28 (0.39–4.17)0.691.27 (0.38–4.27)0.702.27 (0.59–8.69)0.23
Months since dx1.09 (0.92–1.30)0.320.95 (0.83–1.09)0.500.98 (0.86–1.12)0.801.07 (0.93–1.24)0.351.13 (0.98–1.30)0.081.06 (0.92–1.23)0.41
ADT
AbsenceRef.Ref.Ref.Ref.Ref.Ref.
Presence0.53 (0.21–1.35)0.18 2.29 (1.13–4.65) 0.02 1.52 (0.75–3.11)0.25 2.15 (1.05–4.39) 0.04 0.50 (0.25–1.01) 0.06 0.39 (0.18–0.86) 0.02
BSI‐18
Somatisation1.28 (0.96–1.71)0.10 1.24 (1.05–1.48) 0.01 1.29 (1.08–1.54) 0.005 1.09 (0.93–1.28)0.270.89 (0.76–1.04)0.141.08 (0.89–1.30)0.46
Depression0.93 (0.72–1.20)0.561.02 (0.88–1.19)0.801.09 (0.93–1.28)0.300.96 (0.83–1.11)0.591.00 (0.84–1.18)0.971.01 (0.84–1.21)0.93
Anxiety 1.44 (1.00–2.08) 0.05 1.17 (0.97–1.40)0.101.08 (0.89–1.30)0.44 1.20 (1.01–1.43) 0.04 1.18 (0.95–1.45)0.131.24 (0.98–1.56)0.07
EPIC
Urinary0.98 (0.95–1.01)0.17 0.98 (0.96–1.00) 0.02 1.00 (0.98–1.02)0.68 0.97 (0.96–0.99) 0.006 1.00 (0.98–1.02)0.81 0.95 (0.93–0.98) < 0.001
Bowel0.96 (0.90–1.03)0.30 0.95 (0.92–0.99) 0.01 0.98 (0.94–1.01)0.190.99 (0.96–1.02)0.560.97 (0.93–1.00)0.07 0.95 (0.91–1.00) 0.05
Sexual 0.97 (0.96–0.99) < 0.001 1.00 (0.99–1.02)0.61 0.99 (0.97–1.00) 0.01 0.98 (0.97–1.00) 0.007 0.96 (0.95–0.98) < 0.001 0.97 (0.96–0.98) < 0.001

Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis.

The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.

Supportive care needs domains and items (SCNS SF‐34) (N = 331) Level of need for help in the last month. Need was scored 1–2 = no need/need satisfied, 3 = some need, 4–5 = moderate–high need. Top 10 moderate–high supportive care need. n = 262 (69 men receiving androgen deprivation therapy were excluded). Factors associated with unmet supportive care needs in men with prostate cancer (N = 331) Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis. The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.

Help‐seeking and sources of support accessed

Overall, 94% of men reported that they had accessed resources and/or support for their prostate cancer‐related concerns. Excluding resources accessed, 79.5% reported seeking support while 20.5% did not access any form of support. Breaking this down further to examine seeking support from a health professional (doctor, nurse, counselling, or cancer helpline), 61% reported seeking support while 39% did not seek any support from health professional(s) for prostate cancer‐related concerns. The most common resources accessed were brochures or books from the doctor (78%) and the Internet (53%). Sources of support most frequently accessed by men since their prostate cancer diagnosis were a doctor (51%) and family or friends (48%). Local nurse counsellors, cancer helpline, and counselling services and libraries were rarely accessed. While prostate cancer support group use was not high, it was substantially more than other types of counselling services (Table 4).
Table 4

Resources and sources of support accessed since diagnosis (N = 331)

Help accessed%
Resources
Brochures or books from doctor77.6
Internet52.6
Brochures or books from family/friends7.3
Library2.7
Sources of support
Doctor50.8
Family/friends48.0
Nurse/Other health professional17.8
Prostate cancer support group7.9
Cancer Helpline4.5
Counselling service2.1
Local nurse counsellors0.0
Resources and sources of support accessed since diagnosis (N = 331)

Associations between help‐seeking and unmet supportive care needs

Associations between socio‐demographic and treatment characteristics, disease‐specific quality of life, psychological distress, and help‐seeking for men who had some level of need overall and on each supportive care needs domain were examined and results of the logistic regressions are displayed in Table 5. Men who expressed some level of need overall (n = 272) were less likely to seek help if they were older (OR 0.94, CI 0.89–0.99), limited to high school (OR 0.25, CI 0.09–0.74) or primary school (OR 0.07, CI 0.02–0.28) level education and had increased depression symptoms (OR 0.83, CI 0.70–0.98). Being older (OR 0.88, CI 0.80–0.98) and those limited to primary school level education (OR 0.14, CI 0.02–0.90) were associated with a lower likelihood of seeking help for physical and daily living needs. Men who had psychological or health system and information needs were less likely to seek help if they had not progressed beyond primary school level education (ORPsychological 0.09, CI 0.02–0.51; ORHealthSystInfo 0.06, CI 0.01–0.64) and increased depression symptoms (ORPsychological 0.71, CI 0.57–0.87; ORHealthSystInfo 0.77, CI 0.60–1.00). As well, there was a trend for older men with unmet health system and information needs to seek help less often (0.91, CI 0.83–1.00, P = 0.057). Men with unmet sexuality needs were less likely to seek help if they were educated at high school (OR 0.24, CI 0.07–0.90) or primary school (OR 0.10, CI 0.02–0.57) level, more time had passed since diagnosis (OR 0.72, CI 0.53–0.97), they experienced more depression symptoms (OR 0.81, CI 0.66–1.00), and had better bowel function (OR 0.93, CI 0.87–1.00, P = 0.056), with help‐seeking also associated with better sexual function (OR 1.03, CI 1.00–1.06). Being older (OR 0.92, CI 0.86–0.99), educated not further than primary school level (OR 0.08, CI 0.02–0.42), and increased depression (OR 0.83, CI 0.68–1.00) were associated with less help‐seeking for men with prostate cancer‐specific needs.
Table 5

Factors associated with help‐seeking for unmet supportive care needs in men with prostate cancer

Supportive care needsAny need (n = 272)Physical and daily living need (n = 134)Psychological need (n = 156)Health system and info need (n = 102)Sexuality need (n = 192)Prostate cancer‐specific needa (n = 190)
FactorsOR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P
Age (years) 0.94 (0.89–0.99) 0.03 0.88 (0.80–0.98) 0.02 0.92 (0.85–1.01)0.10 0.91 (0.83–1.00) 0.06 0.95 (0.88–1.03)0.20 0.92 (0.86–0.99) 0.03
Education
University/collegeRef.Ref.Ref.Ref.Ref.Ref.
Trade/technical0.38 (0.13–1.14)0.090.58 (0.11–2.93)0.510.66 (0.15–2.89)0.580.43 (0.07–2.69)0.370.69 (0.17–2.80)0.610.31 (0.08–1.27)0.10
High school 0.25 (0.09–0.74) 0.01 0.67 (0.12–3.74)0.650.68 (0.16–2.84)0.590.28 (0.04–1.73)0.17 0.24 (0.07–0.90) 0.03 0.32 (0.08–1.28)0.11
Primary school 0.07 (0.02–0.28) < 0.001 0.14 (0.02–0.90) 0.04 0.09 (0.02–0.51) 0.007 0.06 (0.01–0.64) 0.02 0.10 (0.02–0.57) 0.009 0.08 (0.02–0.42) 0.003
Months since dx0.92 (0.76–1.10)0.360.99 (0.74–1.32)0.950.98 (0.75–1.28)0.880.74 (0.53–1.05)0.09 0.72 (0.53–0.97) 0.03 0.96 (0.77–1.21)0.75
ADT
AbsenceRef.Ref.Ref.Ref.Ref.Ref.
Presence0.82 (0.34–2.01)0.670.85 (0.22–3.19)0.800.49 (0.14–1.76)0.270.98 (0.21–4.65)0.980.42 (0.12–1.50)0.180.92 (0.29–2.90)0.88
BSI‐18
Somatisation1.11 (0.90–1.36)0.321.23 (0.89–1.70)0.201.08 (0.83–1.42)0.561.35 (0.92–1.97)0.121.04 (0.75–1.44)0.811.17 (0.89–1.54)0.25
Depression 0.83 (0.70–0.98) 0.03 0.93 (0.74–1.17)0.51 0.71 (0.57–0.87) 0.001 0.77 (0.60–1.00) 0.05 0.81 (0.66–1.00) 0.05 0.83 (0.68–1.00) 0.05
Anxiety1.09 (0.86–1.40)0.470.88 (0.64–1.22)0.451.28 (0.91–1.80)0.151.23 (0.86–1.78)0.261.10 (0.81–1.50)0.541.07 (0.81–1.41)0.65
EPIC
Urinary1.00 (0.97–1.02)0.821.02 (0.98–1.05)0.351.00 (0.96–1.03)0.811.01 (0.98–1.05)0.470.99 (0.96–1.03)0.721.00 (0.97–1.03)0.93
Bowel0.97 (0.93–1.02)0.200.99 (0.94–1.04)0.650.98 (0.92–1.03)0.390.99 (0.94–1.06)0.93 0.93 (0.87–1.00) 0.06 1.00 (0.95–1.04)0.79
Sexual1.00 (0.98–1.02)0.941.00 (0.97–1.04)0.930.98 (0.96–1.01)0.261.00 (0.96–1.04)0.97 1.03 (1.00–1.06) 0.03 1.01 (0.98–1.03)0.53

Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis.

The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.

Factors associated with help‐seeking for unmet supportive care needs in men with prostate cancer Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis. The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.

Discussion

The present study confirms previous research over the past decade showing a high prevalence of unmet supportive care needs in men with localised prostate cancer (Steginga et al. 2001; Lintz et al. 2003; Smith et al. 2007; Watson et al. 2015). Hence, despite the development of clinical practice guidelines for men with prostate cancer (National Health and Medical Research Council 2003; American Urological Association 2007; Australian Cancer Network Management of Metastatic Prostate Cancer Working Party 2010; Parker et al. 2015) and generic guidelines for psychosocial care in oncology (National Comprehensive Cancer Network 2002; National Breast Cancer Centre and National Cancer Control Initiative 2003; Holland et al. 2011), the pattern of need is unremitting and sexuality needs in particular appear intransigent. These findings have implications moving forward given the recent focus on prostate cancer survivorship guidelines (Skolarus et al. 2014; Resnick et al. 2015) and the observation that knowing what might assist men and actually moving this into practice are different questions (Deane 2014). In this regard, although men may access health care services and do so more frequently as they age, this may not equate to help‐seeking for reproductive health concerns such as erectile dysfunction (Holden et al. 2005, 2006). In a population‐based study of close to 6000 Australian men, 21% reported moderate to severe erectile dysfunction and of these 30% had spoken to a health professional about their condition, with this proportion decreasing by age (17% of men aged ≥70 years had discussed their concerns) (Holden et al. 2005, 2006). Prostate cancer survivors are also less likely to raise their concerns with health care providers (Forsythe et al. 2013), and in particular discuss sexual concerns much less frequently in follow‐up care than concerns about urinary or bowel function (Watson et al. 2015). This creates a challenge for health professionals in terms of how to best identify men with unmet needs and provide accessible support. As well it indicates a need for health care professionals to initiate discussion with men about sexuality irrespective of whether sexual concerns are expressed (Holden et al. 2006; Forsythe et al. 2013). The top three sources of support accessed by men in the present study were the medical professional, nurse and to a lesser extent prostate cancer support groups. These three points of support may present as a triad that if well linked and resourced may have the greatest potential for making a difference in men's unmet needs after prostate cancer diagnosis and treatment. Family and friends as a preferred source of support may also help to promote men's awareness and encourage help‐seeking from available health and supportive care services (Holden et al. 2006; Smith et al. 2006). As well, the high utilisation of the Internet points to this as a key resource that could be leveraged to improve access to self‐management tools as well as professional support. Men who were older, less well educated and more depressed were less likely to seek help despite having unmet needs for support. For age, this may relate to masculine values around stoicism and self‐reliance that may be more strongly held by older men (Chambers et al. 2015a,b) and suggests the importance of continuing to understand the unique challenges faced by specific sub‐groups of men. Level of education likely reflects health literacy that is especially problematic given low health literacy is also related to poorer health outcomes (DeWalt et al. 2004) and poorer use of health services (Berkman et al. 2011). For example, in a population‐based study of Australian men, lower levels of functional health literacy were associated with obstructive sleep apnoea and comorbidities including sedentary lifestyle, depression and cardiovascular disease (Li et al. 2014). The relationship between higher depression and not seeking help speaks to the need for regular assessment of psychosocial needs (Forsythe et al. 2013) including systematic distress screening, rather than waiting for distressed men to self‐present (Chambers et al. 2014). Finally, help‐seeking was associated with better sexual function and this may reflect that men who sought help had better outcomes. Alternatively, it may suggest that men were more likely to seek support for sexuality needs if they had better sexual function. This latter interpretation is consistent with prior research suggesting severity of erectile dysfunction deters help‐seeking such that sexuality interventions may require tailoring to sexual function (Hyde et al. 2016). Strengths of this study include a large cohort of men drawn from a population‐based cancer registry; the use of valid and reliable measures; and addressing the knowledge‐gap regarding associations between supportive care needs and help‐seeking. Limitations include the cross‐sectional design which precludes inferences about causality, and retrospective self‐report assessment of help‐seeking. Longitudinal assessment of supportive care needs for men with localised and advanced prostate cancer and their patterns of help‐seeking are a key focus for future research.

Conclusion

The diagnosis and treatment of prostate cancer is followed by well‐described supportive care needs that are frequently unmet and this was apparent in the current study, particularly for sexuality needs. Few men accessed the range of health professional and community support options available and men with greatest need were least likely to seek support. Older age, lower education, and depression are risk factors for men not seeking help. A new approach to supportive care for men with prostate cancer seems warranted that links across medicine, nursing and community‐based peer support. Future research is needed to establish the optimal mode for intervening to reduce the morbidity associated with this disease.

Conflict of interest

The authors have no conflict of interest, including relevant financial interests, activities, relationships and affiliations to declare.
  48 in total

1.  A new psychosocial screening instrument for use with cancer patients.

Authors:  J Zabora; K BrintzenhofeSzoc; P Jacobsen; B Curbow; S Piantadosi; C Hooker; A Owens; L Derogatis
Journal:  Psychosomatics       Date:  2001 May-Jun       Impact factor: 2.386

2.  Clinical practice guidelines for the psychosocial care of adults with cancer.

Authors:  Jane Turner; Siggi Zapart; Karen Pedersen; Nicole Rankin; Karen Luxford; Jane Fletcher
Journal:  Psychooncology       Date:  2005-03       Impact factor: 3.894

3.  Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.

Authors:  Matthew J Resnick; Christina Lacchetti; Jonathan Bergman; Ralph J Hauke; Karen E Hoffman; Terrence M Kungel; Alicia K Morgans; David F Penson
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

4.  Prospective predictors of psychosocial support service use after cancer.

Authors:  Michelle E McDowell; Stefano Occhipinti; Megan Ferguson; Suzanne K Chambers
Journal:  Psychooncology       Date:  2010-06-07       Impact factor: 3.894

5.  Gender differences of depressive symptoms in depressed and nondepressed elderly persons.

Authors:  M Kockler; R Heun
Journal:  Int J Geriatr Psychiatry       Date:  2002-01       Impact factor: 3.485

6.  Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.

Authors:  Suzanne K Chambers; Robert U Newton; Afaf Girgis; Lisa Nielsen; Stephen Lepore; Cathrine Mihalopoulos; Ra Gardiner; Daniel A Galvão; Stefano Occhipinti
Journal:  BMC Cancer       Date:  2011-07-27       Impact factor: 4.430

7.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

8.  Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic.

Authors:  Kathleen Lintz; Clare Moynihan; Suzanne Steginga; Andy Norman; Ros Eeles; Robert Huddart; David Dearnaley; Maggie Watson
Journal:  Psychooncology       Date:  2003-12       Impact factor: 3.894

9.  Gender Differences in Posttraumatic Stress Disorder and Help Seeking in the U.S. Army.

Authors:  Laurel Hourani; Jason Williams; Robert M Bray; Joshua E Wilk; Charles W Hoge
Journal:  J Womens Health (Larchmt)       Date:  2015-11-12       Impact factor: 2.681

10.  Men's help-seeking in the first year after diagnosis of localised prostate cancer.

Authors:  M K Hyde; R U Newton; D A Galvão; R A Gardiner; S Occhipinti; A Lowe; G A Wittert; S K Chambers
Journal:  Eur J Cancer Care (Engl)       Date:  2016-04-25       Impact factor: 2.520

View more
  12 in total

1.  Mindfulness and Meditative Movement Interventions for Men Living With Cancer: A Meta-analysis.

Authors:  C Graham Ford; Kevin E Vowles; Bruce W Smith; Anita Y Kinney
Journal:  Ann Behav Med       Date:  2020-04-20

Review 2.  Effects of exercise interventions on social and cognitive functioning of men with prostate cancer: a meta-analysis.

Authors:  Yuan-Yuan Fang; Yun-Hsiang Lee; Jui-Chun Chan; Piao-Yi Chiou; Xiao-Yin Chou; Wen-Tzu Chiu; Chia-Tai Hung
Journal:  Support Care Cancer       Date:  2020-01-07       Impact factor: 3.603

3.  New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications.

Authors:  Suzanne K Chambers; Melissa K Hyde; David P Smith; Suzanne Hughes; Susan Yuill; Sam Egger; Dianne L O'Connell; Kevin Stein; Mark Frydenberg; Gary Wittert; Jeff Dunn
Journal:  Psychooncology       Date:  2017-07       Impact factor: 3.894

4.  Prostate care and prostate cancer from the perspectives of undiagnosed men: a systematic review of qualitative research.

Authors:  Ashwini Kannan; Maggie Kirkman; Rasa Ruseckaite; Sue M Evans
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

5.  Men's perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia.

Authors:  Maggie Kirkman; Kate Young; Susan Evans; Jeremy Millar; Jane Fisher; Danielle Mazza; Rasa Ruseckaite
Journal:  BMC Cancer       Date:  2017-10-27       Impact factor: 4.430

6.  Men's help-seeking in the first year after diagnosis of localised prostate cancer.

Authors:  M K Hyde; R U Newton; D A Galvão; R A Gardiner; S Occhipinti; A Lowe; G A Wittert; S K Chambers
Journal:  Eur J Cancer Care (Engl)       Date:  2016-04-25       Impact factor: 2.520

7.  Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.

Authors:  David P Smith; Ross Calopedos; Albert Bang; Xue Qin Yu; Sam Egger; Suzanne Chambers; Dianne L O'Connell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

8.  Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.

Authors:  Clara Breidenbach; Rebecca Roth; Lena Ansmann; Simone Wesselmann; Sebastian Dieng; Ernst-Günther Carl; Günter Feick; Alisa Oesterle; Peter Bach; Burkhard Beyer; Rainer Borowitz; Jörg Erdmann; Frank Kunath; Simba-Joshua Oostdam; Igor Tsaur; Friedemann Zengerling; Christoph Kowalski
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

9.  Social Support in Patients With Sexual Dysfunction After Non-Nerve-Sparing Radical Prostatectomy: A Qualitative Study.

Authors:  Cayetano Fernández-Sola; Álvaro Martínez-Bordajandi; Ana Patricia Puga-Mendoza; José Manuel Hernández-Padilla; Vinicius Jobim-Fischer; María Del Mar López-Rodríguez; José Granero-Molina
Journal:  Am J Mens Health       Date:  2020 Mar-Apr

10.  Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer.

Authors:  Kerri Beckmann; Declan Cahill; Christian Brown; Mieke Van Hemelrijck; Netty Kinsella
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.